Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-antic...
Saved in:
Main Author: | Charlotte L. Bevan |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/feb3485b07fb4d0dbd2023b9e45716e3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
by: Gail P. Risbridger, et al.
Published: (2021) -
Patient-derived xenografts and organoids model therapy response in prostate cancer
by: Sofia Karkampouna, et al.
Published: (2021) -
Breaking Down the LMS Walls
by: Michael Hotrum
Published: (2005) -
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
by: Massimo Moro, et al.
Published: (2017) -
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
by: Miguel Martin, et al.
Published: (2021)